We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Germline mutation in BRAF codon 600 is compatible with human development: de novo p.V600G mutation identified in a patient with CFC syndrome.
- Authors
Champion, K J; Bunag, C; Estep, A L; Jones, J R; Bolt, C H; Rogers, R C; Rauen, K A; Everman, D B
- Abstract
BRAF, the protein product of BRAF, is a serine/threonine protein kinase and one of the direct downstream effectors of Ras. Somatic mutations in BRAF occur in numerous human cancers, whereas germline BRAF mutations cause cardio-facio-cutaneous (CFC) syndrome. One recurrent somatic mutation, p.V600E, is frequently found in several tumor types, such as melanoma, papillary thyroid carcinoma, colon cancer, and ovarian cancer. However, a germline mutation affecting codon 600 has never been described. Here, we present a patient with CFC syndrome and a de novo germline mutation involving codon 600 of BRAF, thus providing the first evidence that a pathogenic germline mutation involving this critical codon is not only compatible with development but can also cause the CFC phenotype. In vitro functional analysis shows that this mutation, which replaces a valine with a glycine at codon 600 (p.V600G), leads to increased ERK and ELK phosphorylation compared to wild-type BRAF but is less strongly activating than the cancer-associated p.V600E mutation.
- Publication
Clinical genetics, 2011, Vol 79, Issue 5, p468
- ISSN
1399-0004
- Publication type
Journal Article
- DOI
10.1111/j.1399-0004.2010.01495.x